Liver Failure after Hydroxycut™ Use in a Patient with Undiagnosed Hereditary Coproporphyria

Journal of General Internal Medicine

Volumn 30, Issue 6, 2015, Pages 856-859

  Haimowitz, Stephanie ^a   Hsieh, Jennifer ^b   Shcherba, Marina ^b   Averbukh, Yelena ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

herbal supplement use; liver failure; porphyria

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COPROPORPHYRIN; HEMIN; PORPHYRIN; COPROPORPHYRINOGEN OXIDASE; HYDROXYCUT; PLANT MEDICINAL PRODUCT;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ACUTE KIDNEY FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; BODY MASS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COPROPORPHYRIA; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEVER; FRAMESHIFT MUTATION; GENERAL CONDITION DETERIORATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LEUKOCYTOSIS; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; NAUSEA; PHOTOSENSITIVITY; RASH; SUPPLEMENTATION; VOMITING; WEIGHT REDUCTION; YOUNG ADULT; BLOOD; COMPLICATION; COPROPORPHYRIA, HEREDITARY; GENETICS;

COPROPORPHYRIA, HEREDITARY; COPROPORPHYRINOGEN OXIDASE; FRAMESHIFT MUTATION; HUMANS; LIVER FAILURE; MALE; PLANT PREPARATIONS; PORPHYRINS; YOUNG ADULT;

EID: 84929844617     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-3153-x     Document Type: Article

References (20)

1. Wintrobe MM, Greer JP.Wintrobe's clinical hematology. 12th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009.
2. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010;375(9718):924–937.
3. Gonzalez-Arriaza HL, Bostwick JM. Acute porphyrias: a case report and review. The American Journal of Psychiatry. 2003;160(3):450–459.
4. Kapetanos D, Xiarchos P, Kapetis E, Avgerinos A, Ilias A, Kokozidis G, Kitis G. Hereditary corpoporphyria presenting with deep jaundice and photosensitivity. Annals of Gastroenterology. 2007;14(4)
5. Dahlgren M, Khosroshahi A, Stone JH. A 22-year-old woman with severe headaches, vomiting, and tonic-clonic seizures. Arthritis Care & Research. 2011;63(1):165–171.
6. Karcz A, Farkas PS. Acute porphyria in the emergency department. The Journal of Emergency Medicine. 1989;7(3):279–285.
7. Hartstein G. The Patient with Porphyria. In: Frost EM, ed. Preanesthetic Assessment 1: Birkhäuser Boston; 1987:166-176
8. Jain G, Bennett JI, Resch DS, Godwin JE. Schizoaffective disorder with missed diagnosis of acute porphyria: a case report and overview. The primary care companion to CNS disorders. 2011;13(6)
9. Foran SE, Abel G. Guide to porphyrias. A historical and clinical perspective. American Journal of Clinical Pathology. 2003;119:S86–93.
10. PF. http://db.porphyriafoundation.com/forms/drug-list.lasso
11. Schmidt M, Schmitz HJ, Baumgart A, Guedon D, Netsch MI, Kreuter MH, et al. Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food ChemToxicol. 2005;43:307–14.
12. Dara L, Hewett J, Lim JK. Hydroxycut™ hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World Journal of Gastroenterology: WJG. 2008;14(45):6999–7004.
13. Sharma T, Wong L, Tsai N, Wong RD. Hydroxycut™((R)) (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature. Hawaii Medical Journal. 2010;69(8):188–190.
14. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement Hydroxycut™. Annals of Internal Medicine. 2005;142(6):477–478.
15. Actis GC, Bugianesi E, Ottobrelli A, Rizzetto M. Fatal liver failure following food supplements during chronic treatment with montelukast. Digestive and Liver Disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2007;39(10):953–955.
16. Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med. 2006;144(1):68–71.
17. Pedrós C, Cereza G, García N, et al. Liver toxicity of Camellia sinensis dried etanolic extract. Med Clin (Barc). 2003;121(15):598–9.
18. Chuah LO, Yeap SK, Ho WY, Beh BK, Alitheen NB. In vitro and in vivo toxicity of garcinia or hydroxycitric acid: a review. Evidence-based Complementary and Alternative Medicine: eCAM. 2012;2012:197920.
19. Pushpalatha T, Reddy PR, Reddy PS. Alterations in hepatic metabolism of adult male rats following exposure to hydroxyprogesterone during embryonic development. Asian J Androl. 2006;8(4):463–7.
20. FDA. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149575.htm